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Abstract
Background: Brucellosis is a zoonotic disease that causes major economic and public health problems. It is one of the most im-
portant diseases in humans and domestic animals. Hence, the exact identification of Brucella spp. is important for strategies of
treatment and control. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) is one of the molecular
techniques characterized by amplification of deoxyribonucleic acid (DNA) sequence and restriction enzyme digestion.
Objectives: This study aimed at identifying genetic polymorphisms of omp2a genes among 90 Brucella isolated from humans and
animals, using the PCR-RFLP method.
Methods: Ninety Brucella spp. isolated from humans and animals in two different regions of Iran were used in this study. Bio-
chemical tests and the Brucella omp2a (1100 bp) gene-PCR was used for identification of Brucella isolates. Polymerase Chain Reaction
products were digested by restriction endonuclease enzyme pstI and gene sequencing analysis was carried out for molecular typing
of Brucella strains. Therefore, genetic relatedness was revealed by a dendrogram.
Results: Analysis of the 90 Brucella strains by biochemical tests, PCR, and PCR-RFLP methods with PstI enzyme and omp2a sequencing
showed four unique RFLP Profiles (P1-P4). Seventy-nine (87.8%) of the Brucella isolates belonged to B. melitensis strain 20236. From 30
animal isolates, nine (30%) belonged to B. melitensis biovare1 and two (6.6%) to B. abortus strain. According to the RFLP dendrogram,
group 1 and 2 had higher genetic relatedness similarity.
Conclusions: The results showed B. melitensis strain 20236 was the predominant strain among human and animal Brucella isolates.
Likewise, according to dendrogram results, the PCR-RFLP technique was not able to separate human and animal species of B. meliten-
sis from B. abortus.
Keywords: Omp2, Pst1, PCR, Brucella,
1. Background
Brucella is a Gram-negative facultative intracellular
bacillus that can infect many human and animal species.
Conventionally, they are classified to seven species, each
of them comprised of several biovars (1). Annually, more
than 500,000 human cases of brucellosis are reported to
the world health organization (2). The prevalence of bru-
cellosis in Iran was reported as 0.5% to 10.9%, in different
provinces (3). Incidence rate of brucellosis was about 66 to
100 per 100,000 population in the province of Hamadan,
Iran (4). Brucellosis still remains an unrestrained problem
in many regions, such as the Middle East, Mediterranean
countries, Latin America, Africa, and some parts of Asia (5).
The disease is endemic and previous studies have reported
that B. melitensis biotype 1 is the predominant strain in hu-
man and animal isolates in Iran (1, 6).
Distinction between species and biovars of Brucella
spp. is currently based on differential tests, such as phe-
notypic characterization of lipopolysaccharides (LPS) anti-
gens, dye-sensitivity, H2S production, phage typing, CO2 re-
quirement, and metabolic properties (7). However, phe-
notypic tests are less sensitive and not always reliable (8).
While, some species of Brucella may be characterized by
serological tests, they are not able to discriminate between
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species and biovars (9). Homology of DNA for all species
in the genus of Brucella is more than 90% and probable
new biovars and strains of Brucella enter the area. Con-
sequently, investigations about the epidemiology of bru-
cellosis, pathogenicity, and ecological differences between
species and biovars of Brucella may help choose the cor-
rect vaccine, plan epidemiological studies, and control
and eradicate the condition (10, 11). Molecular techniques
have shown accurate typing of Brucella spp. based on spe-
cific identification of Brucella nucleotide sequences associ-
ated with the genus, species, and biovars. Therefore, these
methods are important tools for diagnosis in epidemio-
logic studies (12).
Furthermore, PCR-RFLP is a molecular technique ap-
plied by amplification of DNA sequence and restriction
enzyme digestion. However, RFLP analysis is widely used
for the identification of bacterial species and biovars of
the genus Brucella (13). The omp2 locus contains two gene
copies (omp2a and omp2b) coding for porin proteins that
are used for molecular typing and identification of Brucella
at the species, biovar, or strain level (14). The point muta-
tions may effect the sequence amplified and change the di-
agnosis sites of specific restriction enzymes (15). The PCR-
RFLP method has several advantages in comparison to bac-
teriological techniques. It is considered rapid and easy to
performed, cost effective, easy to fit training into labora-
tory schedules, and does not need advanced tools and live
specimens. Disadvantages include need for specific restric-
tion enzymes and failure to identify variations in the nu-
cleic acid sequence analyses (16). This study was the first re-
port to determine the molecular typing of Brucella species
by PCR-RFLP in Hamadan, west of Iran. The aim of this
study was to analyze the epidemiological correlation and
molecular typing of Brucella spp isolated from human and
animals using the PCR-RFLP method.
2. Objectives
This study aimed at identifying genetic polymor-
phisms of omp2a genes among 90 Brucella spp. isolated
from human and animals using the PCR-RFLP method.
Also, it evaluated the genetic diversity and relationship




In total, 90 Brucella strains were isolated from different
sources of humans and animals (cattle, sheep and goat) in
two regions of Iran (Tehran and Hamadan). Sixty Brucella
spp were isolated from blood cultures collected from pa-
tients, who were referred to Sina Hospital of Hamadan with
clinical symptoms, including malaise, arthralgia, myal-
gia, weakness, weight loss, splenomegaly, lymphadenopa-
thy, and serum antibody titers ≥ 1/160. Ten milliliters of
blood from each patient was transferred to the BACTEC
blood culture system (9050 BD Company, U.S.A) and in-
cubated at 37°C for seven day (17). Thirty animal Brucella
isolates were obtained from the Department of Microbiol-
ogy of the Faculty of Medicine, Iran University of Medical
Sciences, Tehran, Iran. These bacteria were isolated from
blood, retropharyngeal, and lymph nodes of animals (cat-
tle, sheep, and goat) that had seropositive tests for brucel-
losis.
3.2. Bacteriological Identification
Brucella strains were grown on 5% sheep Brucella-agar
(Merck, Germany) plates and incubated at 37°C in the pres-
ence of 5% to 10% CO2 for 72 hours. Morphology and bio-
chemical reactions including catalase, oxidase, urease hy-
drolysis tests, CO2 requirement and H2S production was
considered (7). All isolates were cultured on Brucella broth
media (Merck, Germany) with 20% glycerol and stored at
-80°C in the department of microbiology of Hamadan Uni-
versity of Medical Sciences, Hamadan, Iran.
3.3. Polymerase Chain Reaction Assay
DNA was extracted by a modification of the method de-
scribed by Queipo-Ortuno (18). The Brucella isolates were
examined for the presence of omp2a gene by PCR amplifi-
cation (19). Polymerase chain reaction for omp2a was per-
formed in the thermal cycler (Bio-Rad, USA). The Primer se-
quences and condition of PCR is shown in Tables 1 and 2.
Table 1. Polymerase Chain Reaction Mixture
Reaction Volume,µL Company
Mastermix 2X 12.5 Pars Tous Co, IRAN
DN A template 2 -
Primer forward 10 pmol 1 Bioneer Co, Korea
Primer reverse 10 pmol 1 Bioneer Co, Korea
DDH2O 8.5 -
Total volume 25 -
The PCR products were analyzed using the elec-
trophoresis technique on 1.5% agarose gel in 1x Tris-Boric-
EDTA (TBE) buffer. Amplified products were stained by
syber-safe and visualized under UV transilluminator. Bru-
cella abortus S19 strain was used as a positive control and
sterile distilled water was used as a negative control. A 1-kb
plus ladder (Bioneer Co., Korea) was used as the molecular
size marker (20).
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Table 2. Primers Sequences, Temperature Program, and Cycling Conditions for Omp2a –Polymerase Chain Reaction
Primer Sequences
(5′ - 3′)
Amplified Size, bp Primary
Denaturation







1100 95°C/5 min 95°C/ 45 s
53°C/45s (human);
56°C/45s (animal)
72°C/60 s (10, 19)
R- ATCGATTCT-
CACGCTTTCGT
3.4. Digestion of the Polymerase Chain Reaction Products
Polymerase chain reaction-RFLP was used to differen-
tiate all strains of Brucella. The PCR products were di-
gested using Pst I restriction endonuclease enzyme. The
PstI restriction enzyme was used according to the manu-
facturer’s (Thermo, Fermentase, USA) instructions. Briefly,
the digestion mixture included 5 µL of PCR product, 1 µL
enzyme buffers, 0.5µL PstI restriction enzyme (10 to 20 U),
and sterile distilled water up to 15.5 µL. The microtubes
were incubated for four hours at 37°C. The products of RFLP
were electrophoresed on 1.5% agarose gel with Syber-safe
stain, and gel visualized under UV transilluminator. A 100-
bp plus DNA ladder (Bioneer Co., Korea) was used as the
molecular size marker (10).
3.5. PCR-RFLP analysis
Analysis of RFLP patterns was conducted using BioNu-
merics version 7.5 and compared the Dice coefficient and
unweighted pair group method using arithmetic averages
(UPGMA) groups with 0.5% optimization and a 0.5-% band
position tolerance window (21).
4. Results
Ninety Brucella isolates, including 60 (66.7%) human
strains comprised of B. melitensis, and 30 (33.3%) animal
strains, including 28 B. melitensis and 2 B. abortus, were
obtained from different sources and investigated. Phe-
notypic and molecular typing methods were performed
to evaluate the species and the biovar of the Brucella iso-
lates. The morphology and biochemical tests of the iso-
lates showed that they had small colonies with high trans-
parent and smooth surfaces on Brucella agar and gram-
negative coccobacilli with Gram stain, were negative for
H2S production, and positive for urease and oxidase with-
out any necessity for the presence of CO2 and were identi-
fied as B. melitensis. However, the isolates, which were iden-
tified as B. abortus, were positive for oxidase, H2S produc-
tion, urea hydrolysis, and growth in the presence of CO2.
4.1. Polymerase Chain Reaction Results
After identification of Brucella strains by biochemical
standard methods, the isolates were confirmed by the PCR
technique with obtained bands of 1100 bp for omp2a gene
(Figure 1).
Figure 1. The result of omp2a gene amplification in human and animal isolates.
Lane M: molecular ladder 1 kb, lane 1: negative control, lane 2 - 5: animal isolates
of Brucella, lane 6 - 9: H human isolates of Brucella and lane 10: positive control (Bru-
cellaabortus vaccine strain S19).
4.2. PCR-RFLP
According to RFLP dendrogram, four groups (G1 to
G4) and four patterns included P1 (five bands), P2 (four
bands), P3 (four bands), and P4 (three bands), based on the
host sources, were obtained (Figure 2). The created bands
ranged from 60 to 500 bp. The fragments created in each
pattern and the size of their bands is shown in Table 3. Pst1
digestion of the PCR products produced four distinct RFLP
patterns for animal strains (P1 to P4) and two RFLP patterns
(P1 to P2) for human strains (Figure 3).
The omp2a gene sequence of isolates were submitted
to GenBank and assigned by accession number: 06043563.
The PCR-RFLP analysis of omp2a gene is displayed in Table
3.
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Table 3. PCR-RFLP Patterns of Brucella omp2a Gene Digested by Pst1 Enzymea
RFLP Pattern Fragments,
bp
P1 (60, 110, 270, 420, 460) P2 (60, 110, 300, 450) P3 (110, 280, 400, 500) P4 (140, 290, 500) Total
B.melitensis strain
20236
B. abortus B.melitensis strain
20236
B.melitensis Biovar1 B.melitensis Biovar1
Human isolates 24 (40) - 36 (60) - - 60
Animals isolates 8 (26.7) 2 (6.6) 11 (36.7) 6 (20) 3 (10) 30
Total 34 (37.8) 47 (52.2) 6 (6.7) 3 (3.3) 90
aValues are expressed as No. (%).
Figure 2. Dendrogram of omp2a Gene PCR-RFLP. H: human isolates; A: animal iso-
lates.
By gene sequencing analysis of 60 human strains, 100%
of isolates belonged to B. meltensis strain 20236 (P1, P2).
Out of 30 animal Brucella isolates, 19 (63.4%) belonged to
B. meltensis strain 20236 (P1, P2), nine (30%) belonged to B.
meltensis biovare1 (P3, P4), and two (6.6 %) B. abortus (P1) (Ta-
ble 3).
The dendrogram groups were defined by a cutoff value
of 80% similarity, calculated using the BioNumerics soft-
ware package (21).
From a total of 90 Brucella isolates, 24 (26.6%) of the hu-
man strains (B. melitensis), 10 (11%) of the animal strains (B.
melitensis and B. abortus), and B. abortus vaccine strain (S19)
were included in the P1 pattern (Table 3) with whole ge-
netic similarity. Group 2 (P2) contained 36 (40%) of human
(B. melitensis) and 11 (12.2%) of animal strains (B. melitensis)
with complete genetic similarity. Group 3 (P3) and group
4 (P4) contained 6 (6.7%) and 3 (3.3%) of animal strains (B.
melitensis), respectively. Group 2 (52.2%) had the most com-
mon patterns in all Brucella isolates. The dendrogram re-
sults showed a small variation among the isolates.
Figure 3. Agarose gel electrophoresis of pstI restriction fragments of omp2a poly-
merase chain reaction products. Lanes:1, 2, 4, 6, 7, 8 (fragments size: 60, 110, 300, 450
bp (P2)); lanes 3, 5 (fragments size: 60, 110, 270, 420, 460 bp (P1)); lane: 9 (fragments
size: 110, 280, 400, 500 bp (P3)); lane: 10 (fragments size: 140, 290, 500 bp (P4)); lane
M: 100 bp molecular weight marker; lanes: 1 - 3 human isolates and lanes: 4 - 10 ani-
mal isolates.
5. Discussion
Brucellosis is an important bacterial zoonosis, caus-
ing health problems in developing countries. Brucella are
gram negative and facultative intracellular bacteria and
are the causative agent of brucellosis that spread in vari-
ous animal species and humans (22). The current research
studied 60 human and 30 animal Brucella isolates. After
identification of Brucella strains by phenotypic and bio-
chemical tests, the isolates were confirmed for the pres-
ence of omp2a gene by PCR. All strains were omp2a gene
positive. Recently, the PCR technique has increasingly been
performed as a diagnostic and a confirmation method in
Brucella spp. Identification (23, 24). In this study, detection
of polymorphism for all Bruclla isolates by the omp2a gene
as a target of PCR-RFLP and Pst1 enzyme was carried out.
For detection of polymorphism in Brucella spp. omp2a
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and omp2b fragments and several restriction enzymes
were used in various studies (10, 25). In the present study,
similar to other studies in Iran and different parts ofthe
world, amplification of omp2a gene from clinical and an-
imal isolates showed different sizes (50 to 500 bp) (1, 26).
The study conducted by Unver et al. showed that the sizes
of PCR products for clinical isolates of Brucella spp. ranged
from 77 bp to 1200 bp (26).
In the present study, RFLP analysis of the omp2a gene
in 90 Brucella isolates indicated four distinct RFLP pat-
terns in animal isolates and two RFLP profiles in human
isolates (Figure 3). The most common pattern in Brucella
spp. isolated from human and animals in Hamadan and
Tehran was pattern P2. Gene sequencing analysis for Bru-
cella strains showed two profiles including, B. melitensis
strain 20236 with P1 and P2 RFLP patterns in animal and hu-
man Brucella strains and B. melitensis biovar 1 with P3 and
P4 RFLP patterns only in animal isolates. These results in-
dicated that PCR-RFLP of omp2a gene was not able to accu-
rately discriminate human and animal B. melitensis biovars
from each other and from B. abortus. Also, comparable re-
sults were reported by Mirnejad et al. and Pishva et al. (6,
10).
In this study, using gene sequencing, B. melitensis strain
20236 was predominant yet in some other studies, B.
melitensis biovar 1 was the predominant cause of human
and animal brucellosis and it was commonly isolated from
patients and widely spread in some areas of Iran (1, 6, 27).
It has been reported that mixing herds and keeping the
animals in shelters is a major risk factor for transmission
of the infection (28). Iran’s geographical position has al-
ways been an important risk factor in the spread of bru-
cellosis, mainly from eastern and western neighbors, such
as Afghanistan, Pakistan, and Iraq, and it is possible for
new Brucella strains to enter the country (29). These events
may alter the epidemic genotypes of the disease in Iran and
presence of new emerging strains and their source should
be continuously considered.
In the current study, according to RFLP dendrogram,
group 1 (P1) included B. melitensis isolated from humans
and animals, and B. abortus strains isolated from animals.
Group 2 (P2) contained B. melitensis isolated from humans
and animals. Analysis of obtained patterns indicated low
heterogeneity in the omp2 gene of Brucella strains, which
may be due to common clone and same ancestor of Brucella
spp. It is also possible that the bacteria had spread from an-
imals to other animals or humans, and isolates were epi-
demiologically linked and therefore the outbreaks were
likely due to the same species clone. Occurrence of these
events can be directly due to the situation of brucellosis in
animals in relation to the geographical area, and disease
mostly involves people, who are in close contact with ani-
mals, such as veterinarian, ranchers and those, who are ac-
customed to eating goat, sheep, and raw milk (29). There-
fore, defining the origin of infection in human and ani-
mals is also very important.
In this study, according to the results of sequencing,
groups 3 (P3) and 4 (P4) isolated from animals belonged
to B. melitensis biovare1, and another important result indi-
cated complete similarities were not found among the ani-
mal isolates in single clones (G3 and G4). Furthermore, the
B. abortus isolates did not transfer to human through ani-
mals, and this is similar to previous reports from Iran (30,
31). The current results showed different patterns of omp2a
gene in Brucella spp. isolated from animals, and polymor-
phism analysis in omp2a gene will be useful in control
and prevention of infections caused by Brucella strains and
must be performed continuously.
5.1. Conclusions
The current findings, like other studies, confirmed that
the frequency of B. melitensis is higher in human and an-
imal resources and demonstrated that the B. melitensis
strain 20236 was more predominant. Despite the broad ap-
plication of PCR-RFLP in determining the polymorphism
and understanding the epidemiology of important hu-
man pathogens, this technique was unable to differentiate
human and animal species of B. melitensis from B. abortus,
yet gene sequencing analysis could discriminate B. meliten-
sis biovars.
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